Artificial intelligence across oncologic theranostics: evidence for patient stratification, dosimetry, and adaptive radiopharmaceutical therapy.

Banala M, Ezuddin S, Foley M, Kuker R

Open source

DOI
10.3389/fnume.2026.1935247
Published
2026
Container
Frontiers in nuclear medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fnume.2026.1935247,
  title = {Artificial intelligence across oncologic theranostics: evidence for patient stratification, dosimetry, and adaptive radiopharmaceutical therapy.},
  author = {Banala M and Ezuddin S and Foley M and Kuker R},
  year = {2026},
  journal = {Frontiers in nuclear medicine},
  doi = {10.3389/fnume.2026.1935247},
  url = {https://doi.org/10.3389/fnume.2026.1935247}
}

RIS

TY  - JOUR
TI  - Artificial intelligence across oncologic theranostics: evidence for patient stratification, dosimetry, and adaptive radiopharmaceutical therapy.
AU  - Banala M
AU  - Ezuddin S
AU  - Foley M
AU  - Kuker R
PY  - 2026
JO  - Frontiers in nuclear medicine
DO  - 10.3389/fnume.2026.1935247
UR  - https://doi.org/10.3389/fnume.2026.1935247
ER  - 

APA

M, B., S, E., M, F., & R, K. (2026). Artificial intelligence across oncologic theranostics: evidence for patient stratification, dosimetry, and adaptive radiopharmaceutical therapy.. Frontiers in nuclear medicine. https://doi.org/10.3389/fnume.2026.1935247

Source records